Long-term cost-efficacy of rituximab in immune thrombocytopenic purpura

被引：4
|
作者：
Pérez-Calvo, JI [1 ]
Ruiz-Ruiz, F [1 ]
Amores, B [1 ]
Torralba, MA [1 ]
机构：
[1] Hosp Clin Univ Lozano Blesa, Med Interna Serv, Zaragoza, Spain
来源：
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2005年 / 98卷 / 11期
关键词：
D O I：
10.1093/qjmed/hci130
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：839 / 840
页数：2
相关论文
共 50 条
  • [1] Rituximab produces long-term responses in immune thrombocytopenic purpura (ITP).
    Case, DC
    Hedlund, JA
    Ebrahim, KS
    Boyd, MA
    BLOOD, 2005, 106 (11) : 74B - 74B
  • [2] Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura
    Gokcebay, Dilek Gurlek
    Guzelkucuk, Zeliha
    Yarali, Nese
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (03) : 416 - 417
  • [3] Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura
    Jestin, Matthieu
    Benhamou, Ygal
    Schelpe, An-Sofie
    Roose, Elien
    Provot, Francois
    Galicier, Lionel
    Hie, Miguel
    Presne, Claire
    Poullin, Pascale
    Wynckel, Alain
    Saheb, Samir
    Deligny, Christophe
    Servais, Aude
    Girault, Stephane
    Delmas, Yahsou
    Kanouni, Tank
    Lautrette, Alexandre
    Chauveau, Dominique
    Mousson, Christiane
    Perez, Pierre
    Halimi, Jean-Michel
    Charvet-Rumpler, Anne
    Hamidou, Mohamed
    Cathebras, Pascal
    Vanhoorelbeke, Karen
    Veyradier, Agnes
    Coppo, Paul
    BLOOD, 2018, 132 (20) : 2143 - 2153
  • [4] Long-term outcome of splenectomy for immune thrombocytopenic purpura
    Maslanka, K
    Sikorska, A
    Misiak, A
    Konopka, L
    Zupanska, B
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 75 (02) : 117 - 118
  • [5] Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey
    Souleymane Brah
    Laurent Chiche
    Raphaelle Fanciullino
    Charléric Bornet
    Julien Mancini
    Nicolas Schleinitz
    Rodolphe Jean
    Gilles Kaplanski
    Jean-Robert Harlé
    Jean-Marc Durand
    Annals of Hematology, 2012, 91 : 279 - 285
  • [6] Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey
    Brah, Souleymane
    Chiche, Laurent
    Fanciullino, Raphaelle
    Bornet, Charleric
    Mancini, Julien
    Schleinitz, Nicolas
    Jean, Rodolphe
    Kaplanski, Gilles
    Harle, Jean-Robert
    Durand, Jean-Marc
    ANNALS OF HEMATOLOGY, 2012, 91 (02) : 279 - 285
  • [7] Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases
    Vianelli, N
    Galli, M
    de Vivo, A
    Intermesoli, T
    Giannini, B
    Mazzucconi, MG
    Barbui, T
    Tura, S
    Baccarani, M
    HAEMATOLOGICA, 2005, 90 (01) : 72 - 77
  • [8] Long-term remission of thrombotic thrombocytopenic purpura after rituximab.
    Kentouche, K
    Häfer, R
    Zintl, F
    Budde, U
    BLOOD, 2003, 102 (11) : 84B - 84B
  • [9] Long-Term Response to Rituximab in Patients with Relapsing Thrombotic Thrombocytopenic Purpura
    Stein, Gideon Y.
    Blickstein, Dorit
    Orlin, Jerome
    Sarig, Galit
    Inbal, Aida
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (07): : 398 - 401
  • [10] Rituximab therapy for chonic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis
    Garcia-Chavez, Jaime
    Majluf-Cruz, Abraham
    Montiel-Cervantes, Laura
    Esparza, Miriam Garcia-Ruiz
    Vela-Ojeda, Jorge
    ANNALS OF HEMATOLOGY, 2007, 86 (12) : 871 - 877
12345